Cognitive changes in asymptomatic drug-naïve human immunodeficiency virus type 1 clade C infection
Tóm tắt
Asymptomatic human immunodeficiency virus (HIV) infection is associated with impaired cognitive functioning in both clade B and C infections. The nature of cognitive change longitudinally has not been studied in asymptomatic clade C infection. The present study evaluated changes in neuropsychological functioning over a 21/2-year period in a cohort of HIV-1 clade C-infected asymptomatic individuals from South India. Participants with CD4 counts below 250 were started on highly active antiretroviral therapy (HAART) as per National AIDS Control Organisation (NACO) guidelines and hence excluded. The sample consisted of 68 patients (30 men and 38 women), with a mean age of 29.4 years (SD = 5.6 years) and a mean education of 10.0 years (SD =2.7 years). A comprehensive neuropsychological assessment with 12 tests yielding 21 variables was used to examine cognitive functioning at baseline and subsequently at 6-monthly intervals for five follow-ups. Shift in CD4 and viral load categories measured by the McNemar’s test indicated disease progression. Latent growth curve (LGC) modeling assessed the nature of change in cognition over the 21/2-year study period. Ten variables representing attention, executive functions, and long-term memory fit the LGC model. Excepting visual working memory, the slope was nonsignificant for nine variables, indicating absence of deterioration in cognition over a 21/2-year period. However, CD4 and viral load levels worsened, indicating disease progression. Asymptomatic individuals with HIV-1 clade C infection do not show any significant decline on individual neuropsychological functions over 21/2 years despite disease progression, as evidenced by immune suppression and viral loads.
Tài liệu tham khảo
Baldewicz TT, Leserman J, Silva SG, Petitto JM, Golden RN, Perkins DO, Barroso J, Evans DL (2004). Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation. AIDS Behav 8: 345–355.
Byrne BM (2006). Structural equation modeling with EQS, 2nd ed. London: Lawrence Erlbaum Associates.
Das Gupta J, Rao SL, Satishchandra P, Gopukumar, K, Wilkie, FL, Waldrop-Valverde, D, Ellis, R, Ownby, T, Subbakrishna, DK, Desai, A, Kamat, A, Ravi, V, Rao, BS, Satish, KS, Kumar, M (2007). Neuropsychological deficits in HIV-1 clade C-seropositive adults from South India. J NeuroVirol 13: 195–202.
D’Elia, LF, Satz, P, Uchiyama, CL, White, T (1996). Color Trails Test. New York: Psychological Assessment Resources Inc.
Duncan, TE, Duncan, SC, Strycker, LA, Li, A, Alpert, A. (1999). An introduction to Latent variable growth curve modeling: concepts, issues, and applications. Mahwah, NJ: Lawrence Erlbaum.
Bentler, PM (1992). EQS: Structural Equations Program manual. Los Angeles: BMDP Statistical Software.
Grant, I, Atkinson, JH, Hesselink, JR, Kennedy, CJ, Richman, DD, Spector, SA, McCutchan, JA (1987). Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Ann Intern Med 107: 828–836.
Heaton, RK, Grant, I, Nelson, B, White, DA, Kirson, D, Atkinson, HJ (1995). The HNRC 500—neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc 1: 231–251.
Karlsen NR, et al (1993). A follow-up study of neuropsychological function in asymptomatic HIV-infected patients. Acta Neurol Scand 87: 83–87.
Kamat, A, Ravi, V, Desai, A, Satishchchandra, P, Satish, KS, Borodowski, I, Kumar, M (2007). Quantitation of HIV-1 RNA levels in plasma and CSF of asymptomatic HIV-1 infected patients from South India using a TaqMan Real Time PCR assay. J Clin Virol 39: 9–15.
Multicenter AIDS Cohort Study (MACS). Web site located at http://www.statepi.jhsph.edu/macs/macs.html.
McArdle JJ, Epstein DB (1987) Latent growth curves within developmental structural equation models. Child Dev 29: 110–133.
Muthen B (1997) Latent variable modeling with longitudinal and multilevel data. In: Sociological methodology. Raferty A (ed). Boston: Blackwell, pp 453–580.
Rao, SL, Subbakrishna, DK, Gopukumar, K (2004). NIMHANS Neuropsychology Battery—2004 manual. India: NIMHANS Publication.
Selnes, OA, Miller, E, McArthur, J, Gordon, B, Muñoz, A, Sheridan, K, Fox, R, Saah, AJ (1990). No evidence of cognitive decline during the asymptomatic stages. Neurology 40: 204.
Spreen, O, Strauss, J (1998). A compendium of neuropsychological tests. Administration, norms and commentary, 2nd ed. New YorK: Oxford University Press.
Villa, G, Solida, A, Moro, E, Tavolozza, M, Antinori, A, De Luca, A, Murri, R, Tamburrini, E (1996). Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study. Eur Neurol 36: 125–133.
White, DA, Heaton, RK, Monsch, AU, The HNRC Group (1995). Neuropsychological studies of asymptomatic human immunodeficiency virus-type 1 infected individuals. J Int Neuropsychol Soc 1: 304–315.
Willett JB, Sayer AG (1994) Using covariance structure analysis to detect correlates and predictors of individual change over time. Psychol Bull 116: 363–381.
Yepthomi T, Paul R, Vallabhaneni S, Kumarasamy N, Tate DF, Solomon S, Flanigan T (2006). Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus. J Int Neuropsychol Soc 12: 424–430.